| By Schonfeld & Associates, Inc. According to a newly released study from Schonfeld & Associates, Inc., R&D Ratios & Budgets, the pharmaceutical industry continued to be the biggest R&D investor in fiscal 2022 with budgets of drug companies increasing by 8% to $171...
|
| By Schonfeld & Associates, Inc. According to a newly released study from Schonfeld & Associates, Inc., R&D Ratios & Budgets, the pharmaceutical industry continued to be the biggest R&D investor in fiscal 2021 with budgets of drug companies increasing by 24% to $168...
|